Advertisement
Journal Home
Search for

57 Periodical Search Results

You searched for "oestrogen receptor" OR "estrogen receptor" OR "receptors, estrogen" OR "or - oestrogen receptor" OR "e2r - oestrogen receptor" AND "antagonist" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 57 results   Next 20>

Results Page:  [1]  2  3

display abstract citation download email a colleague
Display:

  1. Role of nuclear receptors in lung tumourigenesis
    Raphael A. Nemenoff, Robert A. Winn
    European Journal of Cancer
    November 2005 (Vol. 41, Issue 16, Pages 2561-2568)
    Abstract | Full Text | Full-Text PDF (252 KB)

  1. What clinicians need to know about antioestrogen resistance in breast cancer therapy
    Amalia Milano, Lissandra Dal Lago, Christos Sotiriou, Martine Piccart, Fatima Cardoso
    European Journal of Cancer
    November 2006 (Vol. 42, Issue 16, Pages 2692-2705)
    Abstract | Full Text | Full-Text PDF (385 KB)

  1. The selective oestrogen receptor modulators idoxifene and raloxifene have fundamentally different cell-specific oestrogen-response element (ERE)-dependent/independent mechanisms in vitro
    M.E Nuttall, P.W Fisher, L.J Suva, M Gowen
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 63-64)
    Abstract | Full Text | Full-Text PDF (149 KB)

  1. Selective oestrogen receptor modulation: molecular pharmacology for the millennium
    A.S. Levenson, V.C. Jordan
    European Journal of Cancer
    November 1999 (Vol. 35, Issue 12, Pages 1628-1639)
    Abstract | Full Text | Full-Text PDF (253 KB)

  1. The oestrogen receptor and its selective modulators in gynaecological and breast cancer
    I Vergote, P Neven, P van Dam, R Serreyn, F De Prins, Ph De Sutter, G Albertyn
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 1-9)
    Full Text | Full-Text PDF (120 KB)

  1. Molecular mechanisms of oestrogen — the gynaecologists' viewpoint
    A. Vashisht, J.W.W. Studd
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 14-15)
    Full Text | Full-Text PDF (68 KB)

  1. Endocrine treatment options for advanced breast cancer – the role of fulvestrant
    J.F.R. Robertson, S.E. Come, S.E. Jones, L. Beex, M. Kaufmann, A. Makris, J.W.R. Nortier, K. Possinger, L.-E. Rutqvist
    European Journal of Cancer
    February 2005 (Vol. 41, Issue 3, Pages 346-356)
    Abstract | Full Text | Full-Text PDF (402 KB)

  1. Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer
    J.F.R Robertson, P.C Willsher, L Winterbottom, R.W Blamey, S Thorpe
    European Journal of Cancer
    February 1999 (Vol. 35, Issue 2, Pages 214-218)
    Abstract | Full Text | Full-Text PDF (115 KB)

  1. Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?
    S. Pignata, B. Daniele, C. Gallo, R. De Vivo, S. Monfardini, F. Perrone
    European Journal of Cancer
    January 1998 (Vol. 34, Issue 1, Pages 25-32)
    Abstract | Full Text | Full-Text PDF (104 KB)

  1. Structural insights into the mechanisms of agonism and antagonism in oestrogen receptor isoforms
    R.E. Hubbard, A.C.W. Pike, A.M. Brzozowski, J. Walton, T. Bonn, J.-Å. Gustafsson, M. Carlquist
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 17-18)
    Abstract | Full Text | Full-Text PDF (66 KB)

  1. Selective oestrogen receptor modulation: molecular pharmacology for the millennium
    A.S. Levenson, V.C. Jordan
    European Journal of Cancer
    December 1999 (Vol. 35, Issue 14, Pages 1974-1985)
    Abstract | Full Text | Full-Text PDF (374 KB)

  1. Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells
    N Sathyamoorthy, T.T.Y Wang
    European Journal of Cancer
    December 1997 (Vol. 33, Issue 14, Pages 2384-2389)
    Abstract | Full Text | Full-Text PDF (274 KB)

  1. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
    P.A Konstantinopoulos, A Kominea, G Vandoros, G.P Sykiotis, P Andricopoulos, I Varakis, G Sotiropoulou-Bonikou, A.G Papavassiliou
    European Journal of Cancer
    June 2003 (Vol. 39, Issue 9, Pages 1251-1258)
    Abstract | Full Text | Full-Text PDF (456 KB)

  1. Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancer
    J.F.R. Robertson, V. Semiglazov, G. Nemsadze, G. Dzagnidze, M. Janjalia, R.I. Nicholson, J.M.W. Gee, J. Armstrong, for the Study 41 Investigators
    European Journal of Cancer
    January 2007 (Vol. 43, Issue 1, Pages 64-70)
    Abstract | Full Text | Full-Text PDF (127 KB)

  1. Selective oestrogen receptor downregulator
    Anthony A. Howell
    European Journal of Cancer
    September 2002 (Vol. 38Supplement 6, Pages 61-62)
    Full Text | Full-Text PDF (59 KB)

  1. Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer , 17 December 2007
    O.E. Young, L. Renshaw, E.J. Macaskill, S. White, D. Faratian, J.St.J. Thomas, J.M. Dixon
    European Journal of Cancer
    February 2008 (Vol. 44, Issue 3, Pages 391-399)
    Abstract | Full Text | Full-Text PDF (177 KB)

  1. The oestrogen receptor and its selective modulators in gynaecological oncology
    M Seifert, A Galid, E Kubista
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 66-67)
    Full Text | Full-Text PDF (64 KB)

  1. The α1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-κB signalling to induce breast cancer cell apoptosis , 26 November 2007
    Hongxiang Hui, Manory A. Fernando, Anthony P. Heaney
    European Journal of Cancer
    January 2008 (Vol. 44, Issue 1, Pages 160-166)
    Abstract | Full Text | Full-Text PDF (405 KB)

  1. Tamoxifen: Catalyst for the change to targeted therapy , 10 December 2007
    V. Craig Jordan
    European Journal of Cancer
    January 2008 (Vol. 44, Issue 1, Pages 30-38)
    Abstract | Full Text | Full-Text PDF (539 KB)

  1. IL-1α gene expression in human endometrial cancer is independent of ovarian steroid receptor expression
    C.F Singer, N Kronsteiner, E Marton, I Walter, M Kubista, K Czerwenka, M Schreiber, W Tschugguel, F Wieser, E Kubista
    European Journal of Cancer
    September 2002 (Vol. 38Supplement 6, Pages 76-77)
    Full Text | Full-Text PDF (64 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 57 results   Next 20>

Results Page:  [1]  2  3

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement